Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07798915.0Aexternal-prioritypatent/EP2037922B9/en
Application filed by Glaxosmithkline LlcfiledCriticalGlaxosmithkline Llc
Publication of CY1115011T1publicationCriticalpatent/CY1115011T1/en
Η εφεύρεση που περιγράφεται εδώ σχετίζεται με ορισμένα παράγωγα πυριμιδινοτριόνης Ν-υποκατεστημένης γλυκίνης του τύπου (I), (I) που είναι ανταγωνιστές των HIF προλυλο υδροξυλασών και είναι χρήσιμα για τη θεραπεία ασθενειών που επωφελούνται από την αναστολή αυτού του ενζύμου, παράδειγμα των οποίων είναι η αναιμία.The invention described herein relates to certain N-substituted glycine pyrimidinotrione derivatives of formula (I), (I) which are antagonists of HIF prolyl hydroxylases and are useful for the treatment of diseases that benefit from inhibition of this enzyme, examples of which are anemia.
CY20141100256T2006-06-232014-04-04
HYDROXYL POSITION Suspensions
CY1115011T1
(en)